[Immunological analysis of hydatidiform mole and invasive mole (author's transl)]. 1980

K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi

Thirty-two cases of hydatidiform mole without endometrial invasion of chorial tissue and 17 of invasive mole were studied to ascertain whether these two diseases can be differentiated by various immune parameters. All of hydatidiform 11 of invasive mole were sampled at a state of "mole in utero" (pre-evacuation), but 6 of invasive mole were at a post-evacuation state, respectively. The results were summarized in the following items; 1. Serum total protein, especially albumin decreased with no significant difference in both groups. Globulin fractionation (alpha 1, alpha 2, beta, gamma-globulin) showed no characteristic changes. 2. A variation of immunoglobin (IgG, IgM, IgA) was similar in both. 3. Beta 1 C (a component of complement) increased in two groups, but no difference was revealed. 4. Leucocytosis was observed, but lymphocytosis was not detected in both groups. 5. Active E-RFC slightly increased, although total E-RFC and EAC-RFC were within normal range. But these findings were not statistically different in both. 6. In vitro lymphocyte-PHA-response was fairly depressed without a significant difference in two groups. 7. Suppressive effect of serum on lymphocyte-response was also slightly strengthened, but a difference in both was not significant. 8. The results of immune skin tests (PHA, PPD, SK-SD, Candida) could not be debated with liquid numbers studied.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002820 Hydatidiform Mole, Invasive A uterine tumor derived from persistent gestational TROPHOBLASTS, most likely after a molar pregnancy (HYDATIDIFORM MOLE). Invasive hyadatiform mole develops in about 15% of patients after evacuation of a complete mole and less frequently after other types of gestation. It may perforate the MYOMETRIUM and erode uterine vessels causing hemorrhage. Chorioadenoma,Invasive Mole,Chorioadenomas,Hydatidiform Moles, Invasive,Invasive Hydatidiform Mole,Invasive Hydatidiform Moles,Invasive Moles,Mole, Invasive,Mole, Invasive Hydatidiform,Moles, Invasive,Moles, Invasive Hydatidiform
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006828 Hydatidiform Mole Trophoblastic hyperplasia associated with normal gestation, or molar pregnancy. It is characterized by the swelling of the CHORIONIC VILLI and elevated human CHORIONIC GONADOTROPIN. Hydatidiform moles or molar pregnancy may be categorized as complete or partial based on their gross morphology, histopathology, and karyotype. Molar Pregnancy,Pregnancy, Molar,Hydatid Mole,Hydatidiform Mole, Complete,Hydatidiform Mole, Partial,Complete Hydatidiform Mole,Complete Hydatidiform Moles,Hydatid Moles,Hydatidiform Moles,Hydatidiform Moles, Complete,Hydatidiform Moles, Partial,Molar Pregnancies,Mole, Complete Hydatidiform,Mole, Hydatid,Mole, Hydatidiform,Mole, Partial Hydatidiform,Moles, Complete Hydatidiform,Moles, Hydatid,Moles, Hydatidiform,Moles, Partial Hydatidiform,Partial Hydatidiform Mole,Partial Hydatidiform Moles,Pregnancies, Molar
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin

Related Publications

K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
February 1981, Acta obstetrica et gynaecologica Japonica,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
December 1980, Acta obstetrica et gynaecologica Japonica,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
December 1973, Ceskoslovenska gynekologie,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
April 1980, Geburtshilfe und Frauenheilkunde,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
April 1949, American journal of obstetrics and gynecology,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
August 1949, The Journal of obstetrics and gynaecology of the British Empire,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
January 1952, Canadian Medical Association journal,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
February 1967, The Journal of obstetrics and gynaecology of the British Commonwealth,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
July 1982, Nihon Sanka Fujinka Gakkai zasshi,
K Kanazawa, and M Ohno, and H Yuzawa, and Y Takeuchi, and K Takaishi, and S Nakamura, and H Yoshizawa, and S Takeuchi
August 1982, Ugeskrift for laeger,
Copied contents to your clipboard!